Instituto Bernabeu Madrid
Instituto Bernabeu is a Spanish fertility clinic network operating nine clinics across Spain and Italy, providing IVF, egg donation, proprietary genetic testing, and AI-assisted reproductive medicine to individual patients with infertility. Acquired by Eugin Group in January 2026.
- Company typePrivate
- Founded1985
- HeadquartersMadrid, Spain
- Headcount—
- GTM typeB2C
- OfferingServices
What Instituto Bernabeu Madrid does
Instituto Bernabeu is a Spanish reproductive medicine clinic network founded in 1985 and headquartered in Alicante, operating nine clinics across Spain (Alicante, two in Madrid, Palma de Mallorca, Cartagena, Albacete, Elche, Benidorm) and Italy (Venice). The Madrid center specifically was established in 2017. The company provides comprehensive fertility services including IVF, egg donation, embryo adoption, artificial insemination, ICSI, the ROPA method for lesbian couples, single-woman motherhood, and fertility preservation, serving primarily individual consumers experiencing infertility, recurrent implantation failure, low ovarian reserve, endometriosis, or male-factor infertility.
The company's technology stack centers on a proprietary suite of genetic diagnostic tests under the IBgen brand (IBgen FIV for ovarian reserve pharmacogenetics, IBgen FOP analyzing 512 genes for premature ovarian failure, IBgen RIF for implantation failure, IBgen Sperm for male fertility, TCG for genetic compatibility), supported by advanced embryology techniques including AI-powered time-lapse incubators, array-CGH comprehensive chromosome screening, MACS sperm selection, and experimental ovarian rejuvenation (PRP and cortex fragmentation). A dedicated International AI Unit, formally launched in April 2024, consolidates AI/ML applications across the treatment pipeline, from embryo selection to pharmacogenetic optimization. In March 2026, the company announced a patented sperm identification plate claiming up to 10% improvement in embryo quality.
Revenue is generated primarily through one-time treatment fees for assisted reproduction procedures, supplemented by diagnostic genetic testing and associated medical services (gynecology, obstetrics, urology, psychology). The company operates a direct-to-consumer model via in-person consultations, video consultations, 10-language support, financing options, and a pregnancy guarantee program (Única) offering refunds if treatment fails. Pricing is not publicly disclosed. In January 2026, Instituto Bernabeu was acquired by Eugin Group, an international fertility services provider, creating the second-largest fertility group in Spain.
Instituto Bernabeu Madrid firmographics
Firmographics- Name
- Instituto Bernabeu Madrid
- Legal name
- Instituto Bernabeu
- Website
- https://institutobernabeu.com
- Company type
- Private
- Founded year
- 1985
- Operating status
- Operating
- Short description
- Instituto Bernabeu is a Spanish fertility clinic network operating nine clinics across Spain and Italy, providing IVF, egg donation, proprietary genetic testing, and AI-assisted reproductive medicine to individual patients with infertility. Acquired by Eugin Group in January 2026.
- Ownership category
- akta.pro rank
Instituto Bernabeu Madrid industry classification
Industry- Product category
- Fertility and Reproductive Medicine Services
- NAICS
- Medical and Diagnostic Laboratories (62151), Medical and Diagnostic Laboratories (6215), Family Planning Centers (621410)
- SIC
- Services-Medical Laboratories (8071), Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093), In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Fertility, Reproductive Endocrinology & IVF Centers (HLAFAJAD)
- akta.pro secondary industries
- Reproductive Endocrinology & Infertility (IVF/Fertility) (HLAKAJAC), Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening) (HLAAALAJ), Genetic & Prenatal Testing Laboratories (HLAFAMAH)
Keywords
Where Instituto Bernabeu Madrid is headquartered
LocationHeadquarters
- HQ city
- Madrid
- HQ country
- Spain
- HQ region
- Europe
Offices9 records
Markets served
Instituto Bernabeu Madrid business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Assisted Reproduction Medical Services: Revenue generated from fertility treatments including IVF, egg donation, embryo adoption, artificial insemination, ROPA method, egg and sperm freezing. Services are priced as one-time procedures with financing options available.
- Diagnostic Genetic Testing: Revenue from proprietary genetic tests including IBgen FIV, IBgen FOP, IBgen RIF, IBgen sperm, TCG genetic compatibility test, and microbiome studies. These are individual diagnostic services.
- Associated Medical Services: Revenue from related healthcare services including gynecology, obstetrics, andrology, urology, endocrinology, acupuncture, and psychological support.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels6 records
Instituto Bernabeu Madrid product offering
Product offeringCore offering
Instituto Bernabeu Madrid is a reproductive medicine clinic delivering fertility treatments and assisted reproduction services, including in vitro fertilization (IVF), egg donation (Ovodonación), ICSI, artificial insemination, embryo adoption, the ROPA method, and fertility preservation (egg and sperm freezing). The clinic complements these treatments with proprietary genetic diagnostic tests under the IBgen brand, advanced laboratory techniques (time-lapse embryo monitoring, array-CGH/CCS, MACS sperm selection), and a pregnancy guarantee program (Única).
Product overview
Instituto Bernabeu is a reproductive medicine clinic offering a comprehensive portfolio of fertility treatments and diagnostic services. The core offerings include assisted reproduction techniques such as IVF (Fecundación In Vitro), egg donation (Ovodonación), artificial insemination, ICSI, embryo adoption, and the ROPA method for lesbian couples. Advanced techniques include preimplantation genetic testing (DGP/PGT), time-lapse embryo monitoring with AI, array-CGH comprehensive chromosome screening, and sperm selection techniques. The clinic operates proprietary genetic diagnostic tests under the IBgen brand (IBgen FIV for ovarian reserve, IBgen RIF for implantation failure, IBgen FOP for ovarian failure, IBgen Sperm for male fertility, and TCG for genetic compatibility). Specialized units address specific conditions including low ovarian response, endometriosis, recurrent miscarriage, and an International AI Unit applying artificial intelligence throughout the treatment pipeline. The clinic also offers a pregnancy guarantee program (Única).
Differentiator
Problem solved
Functional benefit
Brands
- IBgen FIV: Genetic study of ovarian reserve to define medication for IVF treatment
- IBgen RIF
- IBgen FOP
- IB Biotech
- UNICA Bernabeu
Products and services
- Fecundación In Vitro (FIV) In vitro fertilization treatment involving egg retrieval, laboratory fertilization, and embryo transfer for couples with fertility challenges.
- Ovodonación (Egg Donation) IVF treatment using donated eggs from anonymous donors for patients who cannot produce viable oocytes.
- Inseminación Artificial (Artificial Insemination) Artificial insemination procedure using prepared sperm to facilitate fertilization.
- ICSI (Intracytoplasmic Sperm Injection) Intracytoplasmic sperm injection technique where a single sperm is directly injected into the egg for fertilization.
- Diagnóstico Genético Preimplantacional (DGP/PGT) Preimplantation genetic testing to screen embryos for chromosomal abnormalities and genetic disorders before transfer.
- Congelación de Embriones (Cryotransferencia) Embryo cryopreservation and frozen embryo transfer procedures.
- Incubadoras Time-Lapse Time-lapse incubator systems with AI-powered embryo monitoring and continuous selection for improved embryo viability assessment.
- Adopción de Embriones (Embryo Adoption) Embryo adoption program allowing patients to receive donated embryos.
- Método ROPA (Reception of Oocytes from Partner) Reception of oocytes from partner (ROPA) for lesbian couples to share motherhood, where one partner provides eggs and the other carries the pregnancy.
- Preservación de Fertilidad (Egg Freezing) Egg freezing and fertility preservation for women who wish to delay motherhood or preserve fertility before medical treatments.
- IBgen FIV - Genetic Study of Ovarian Reserve Pharmacogenetic test analyzing variants in FSH receptor, androgen receptor, ESR1, and AMHR2 genes to predict ovarian response and optimize medication selection for IVF treatment.
- IBgen RIF - Recurrent Implantation Failure and Miscarriage Genetic Test Comprehensive genetic test analyzing thrombotic, immunological, and endometrial receptivity genetic variants to diagnose causes of recurrent implantation failure and pregnancy loss.
- IBgen FOP - Genetic Study of Ovarian Failure NGS-based genetic analysis examining 512 genes to identify mutations causing premature ovarian insufficiency for personalized treatment planning.
- IBgen Sperm - Male Fertility Genetic Test Male fertility genetic test analyzing spermatogenesis genes to diagnose genetic causes of male infertility.
- TCG - Genetic Compatibility Test Genetic compatibility test for couples to assess risk of transmitting genetic disorders to offspring.
- MACS and Other Sperm Selection Techniques Magnetic-activated cell sorting (MACS) and other sperm selection techniques to identify the most viable sperm for ICSI procedures.
- Programa Garantía de Embarazo (Única) Pregnancy guarantee program offering full refund if pregnancy is not achieved after completing the treatment protocol.
Quantifiable outcome
- Up to 70% live birth rate with array-CGH/CCS in patients with implantation failure or recurrent miscarriage
Companies that use Instituto Bernabeu Madrid
Customer profileSegments1 record
Ideal customer profiles2 records
Instituto Bernabeu Madrid technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability8 records
Feature8 records
Instituto Bernabeu Madrid partnerships and signals
Strategic signalScale indicators3 records
Recent moves6 records
Expansion highlights5 records
Instituto Bernabeu Madrid competitors and assessment
Company assessmentDirect peers
- Fertty International: Barcelona-based IVF clinic with a strong egg-donation and international-patient focus; competes with Instituto Bernabeu in the Spanish fertility market and for cross-border medical tourism patients.
- CREA (Centro Médico de Reproducción Asistida): Valencia-based fertility clinic offering IVF, ICSI, and PGT services; geographic and service-line overlap with Instituto Bernabeu's Alicante HQ and broader Spanish network.
- ProcreaTec: Madrid fertility clinic specializing in IVF, PGT, and reproductive genetics; directly comparable to Instituto Bernabeu's Madrid offerings, particularly in advanced genetic testing and personalized treatment.
- Clinica Tambre: Madrid-based fertility clinic offering IVF, ICSI, egg donation, and advanced reproductive techniques; competes head-to-head with Instituto Bernabeu's Madrid (Velázquez/Ayala) clinics for Spanish and international patients.
- IVI-RMA Global (GeneraLife): Largest fertility clinic network in Spain and a leading global IVF operator; directly competes with Instituto Bernabeu across IVF, egg donation, and PGT services, and is now the larger Spanish fertility platform that the Eugin–Bernabeu combination is benchmarked against.
- Reproclinic: Barcelona fertility clinic offering IVF, egg donation, and PGT; comparable to Instituto Bernabeu on service portfolio and on the Spanish international-patient segment.
- Vida Fertility Institute: Multi-clinic Spanish fertility operator with locations in Madrid, Barcelona, and Alicante; competes directly with Instituto Bernabeu in IVF, egg donation, and fertility preservation.
Broad incumbents
- Eugin Group: International fertility services group and now the parent company of Instituto Bernabeu following the January 2026 acquisition; operates IVF clinics across Europe and provides the most direct strategic comparable given overlapping service lines and the second-largest-in-Spain positioning.
Regional players
- Virtus Health: Australia/UK-listed fertility services operator with global clinic footprint; useful international benchmark for a multi-clinic IVF platform with diagnostic and genetic capabilities, though it does not directly compete in the Iberian market.
- Boston IVF: Large US fertility clinic network; comparable as a multi-site fertility platform with advanced PGT/AI capabilities, but operates in North America rather than competing directly in Spain or Italy.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Instituto Bernabeu Madrid social profiles
Digital presenceInstituto Bernabeu Madrid compliance and trust
Trust signalCompliance12 records
Instituto Bernabeu Madrid financial estimates
Financial estimateRevenue estimate
Valuation estimate
Instituto Bernabeu Madrid leadership team
Management profileNumber of profiles
Profiles4 records
Instituto Bernabeu Madrid subsidiaries and ownership
Company hierarchySubsidiaries2 records
Instituto Bernabeu Madrid funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Instituto Bernabeu Madrid M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Instituto Bernabeu Madrid
What does Instituto Bernabeu Madrid do?
Instituto Bernabeu Madrid is a reproductive medicine clinic delivering fertility treatments and assisted reproduction services, including in vitro fertilization (IVF), egg donation (Ovodonación), ICSI, artificial insemination, embryo adoption, the ROPA method, and fertility preservation (egg and sperm freezing). The clinic complements these treatments with proprietary genetic diagnostic tests under the IBgen brand, advanced laboratory techniques (time-lapse embryo monitoring, array-CGH/CCS, MACS sperm selection), and a pregnancy guarantee program (Única).
Is Instituto Bernabeu Madrid a public or private company?
Instituto Bernabeu Madrid is a private company. It is classified as corporate owned and is currently operating.
When was Instituto Bernabeu Madrid founded?
Instituto Bernabeu Madrid was founded in 1985.
Where is Instituto Bernabeu Madrid based?
Instituto Bernabeu Madrid is headquartered in Madrid, Spain, in the Europe region.
How does Instituto Bernabeu Madrid make money?
Three revenue lines are on record. Assisted Reproduction Medical Services are the primary driver. The others are diagnostic Genetic Testing and associated Medical Services.
Who are Instituto Bernabeu Madrid's main competitors?
Direct peers on record are Fertty International, CREA (Centro Médico de Reproducción Asistida), ProcreaTec, Clinica Tambre, IVI-RMA Global (GeneraLife), Reproclinic and Vida Fertility Institute. Eugin Group is listed as a broad incumbent. Regional players are Virtus Health and Boston IVF.
Does Instituto Bernabeu Madrid have an API?
No public API is recorded for Instituto Bernabeu Madrid.
What industry is Instituto Bernabeu Madrid in?
Instituto Bernabeu Madrid's product category is Fertility and Reproductive Medicine Services. Its primary akta.pro industry code is HLAFAJAD, Fertility, Reproductive Endocrinology & IVF Centers, with a secondary code of HLAKAJAC, Reproductive Endocrinology & Infertility (IVF/Fertility). Its NAICS code is 62151 and its SIC code is 8071.